{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:12:05Z","timestamp":1780333925373,"version":"3.54.1"},"reference-count":34,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2017.00369","type":"journal-article","created":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T13:51:56Z","timestamp":1497361916000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":98,"title":["Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still\u2019s Disease: A Multicentre Retrospective Observational Study"],"prefix":"10.3389","volume":"8","author":[{"given":"Serena","family":"Colafrancesco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Priori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Valesini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Argolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Baldissera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bartoloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Cammelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Canestrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cantarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Cavallaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Cavalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Cerrito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Dagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginevra De","family":"Marchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore De","family":"Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Emmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Ferraccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micol","family":"Frassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Galeazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gerli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Gremese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florenzo","family":"Iannone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Lapadula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lopalco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Manna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlomaurizio","family":"Montecucco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mosca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Piga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Pontikaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micol","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Rossini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Ruscitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Stagnaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Talarico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Tincani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ombretta","family":"Viapiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Vitiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Fabris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bindoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Punzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Galozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Sfriso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,6,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000082","article-title":"Successful treatment of refractory adult-onset still disease with canakinumab: a case report.","volume":"20","author":"Barsotti","year":"2014","journal-title":"J. Clin. Rheumatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3109\/03009742.2014.992949","article-title":"Efficacy and safety of biological agents in adult-onset Still\u2019s disease.","volume":"44","author":"Cavalli","year":"2015","journal-title":"Scand. J. Rheumatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1345\/aph.1E425","article-title":"Leflunomide and azathioprine combination in refractory adult-onset Still\u2019s disease.","volume":"39","author":"Cefle","year":"2005","journal-title":"Ann. Pharmacother."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/156890","article-title":"IL-18 serum level in adult onset Still\u2019s disease: a marker of disease activity.","volume":"2012","author":"Colafrancesco","year":"2012","journal-title":"Int. J. Inflamm."},{"key":"B5","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1586\/1744666X.2015.1037287","article-title":"Presentation and diagnosis of adult-onset Still\u2019s disease: the implications of current and emerging markers in overcoming the diagnostic challenge.","volume":"11","author":"Colafrancesco","year":"2015","journal-title":"Expert Rev. Clin. Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases.","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/ard.2004.024026","article-title":"Tumour necrosis factor alpha blocking agents in refractory adult Still\u2019s disease: an observational study of 20 cases.","volume":"64","author":"Fautrel","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"B8","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/rheumatology\/40.12.1398","article-title":"Cytokine and immunogenetic profiles in Japanese patients with adult Still\u2019s disease. Association with chronic articular disease.","volume":"40","author":"Fujii","year":"2001","journal-title":"Rheumatology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still\u2019s disease.","volume":"13","author":"Gerfaud-Valentin","year":"","journal-title":"Autoimmun. Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/MD.0000000000000021","article-title":"Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients.","volume":"93","author":"Gerfaud-Valentin","year":"","journal-title":"Medicine"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/317820","article-title":"Anti-interleukin-1 agents in adult onset Still\u2019s disease.","volume":"2012","author":"Giampietro","year":"2012","journal-title":"Int. J. Inflamm."},{"key":"B12","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/acr.21901","article-title":"Anakinra in adult-onset Still\u2019s disease: long-term treatment in patients resistant to conventional therapy.","volume":"65","author":"Giampietro","year":"2013","journal-title":"Arthritis Care Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.2147\/DDDT.S73428","article-title":"Interleukin 1 inhibition with anakinra in adult-onset Still disease: a meta-analysis of its efficacy and safety.","volume":"8","author":"Hong","year":"2014","journal-title":"Drug Des. Dev. Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2147\/TCRM.S64951","article-title":"Treatment of adult-onset Still\u2019s disease: a review.","volume":"11","author":"Jamilloux","year":"2015","journal-title":"Ther. Clin. Risk Manag."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00296-011-1801-6","article-title":"Therapeutic responses and prognosis in adult-onset Still\u2019s disease.","volume":"32","author":"Kim","year":"2012","journal-title":"Rheumatol. Int."},{"key":"B16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.semarthrit.2012.03.004","article-title":"The use of Canakinumab, a novel IL-1beta long-acting inhibitor, in refractory adult-onset Still\u2019s disease.","volume":"42","author":"Kontzias","year":"2012","journal-title":"Semin. Arthritis Rheum."},{"key":"B17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.semarthrit.2007.04.002","article-title":"Anakinra in patients with treatment-resistant adult-onset Still\u2019s disease: four case reports with serial cytokine measurements and a review of the literature.","volume":"37","author":"K\u00f6tter","year":"2007","journal-title":"Semin. Arthritis Rheum."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/ar3366","article-title":"Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still\u2019s disease: a case-series study.","volume":"13","author":"Laskari","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1136\/ard.2007.076034","article-title":"Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France.","volume":"67","author":"Lequerr\u00e9","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jbspin.2013.12.011","article-title":"Canakinumab in a case of adult onset still\u2019s disease: efficacy only on systemic manifestations.","volume":"81","author":"Lo Gullo","year":"2014","journal-title":"Joint Bone Spine"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.autrev.2014.08.032","article-title":"Adult onset Still\u2019s disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions.","volume":"13","author":"Maria","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-015-0047-3","article-title":"Gene-expression analysis of adult-onset Still\u2019s disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity.","volume":"13","author":"Nirmala","year":"2015","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"B23","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.3899\/jrheum.111549","article-title":"Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still\u2019s disease. An open, randomized, multicenter study.","volume":"39","author":"Nordstr\u00f6m","year":"2012","journal-title":"J. Rheumatol."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001554","article-title":"Efficacy of anakinra in refractory adult-onset Still\u2019s disease: multicenter study of 41 patients and literature review.","volume":"94","author":"Ortiz-Sanju\u00e1n","year":"2015","journal-title":"Medicine"},{"key":"B25","first-page":"933","article-title":"Clinical, biological and sonographic response to IL-1 blockade in adult-onset Still\u2019s disease.","volume":"26","author":"Priori","year":"2008","journal-title":"Clin. Exp. Rheumatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3899\/jrheum.130575","article-title":"Interleukin 18: a biomarker for differential diagnosis between adult-onset Still\u2019s disease and sepsis.","volume":"41","author":"Priori","year":"2014","journal-title":"J. Rheumatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.3899\/jrheum.100247","article-title":"Clinical manifestations but not cytokine profiles differentiate adult-onset Still\u2019s disease and sepsis.","volume":"37","author":"Rau","year":"2010","journal-title":"J. Rheumatol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0228-7","article-title":"Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey.","volume":"10","author":"Rossi-Semerano","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/01.rhu.0000089966.48691.7f","article-title":"Successful treatment of a patient with refractory adult-onset still disease with anakinra.","volume":"9","author":"Rudinskaya","year":"2003","journal-title":"J. Clin. Rheumatol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0738-8","article-title":"Adult-onset Still\u2019s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers.","volume":"14","author":"Ruscitti","year":"2016","journal-title":"BMC Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s10067-016-3308-8","article-title":"Adult-onset Still\u2019s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients.","volume":"35","author":"Sfriso","year":"2016","journal-title":"Clin. Rheumatol."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00380","article-title":"A snapshot on the on-label and off-label use of the interleukin-1 inhibitors in Italy among rheumatologists and pediatric rheumatologists: a nationwide multi-center retrospective observational study.","volume":"7","author":"Vitale","year":"2016","journal-title":"Front. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.3105cm1","article-title":"Interleukin-1 (IL-1) pathway.","volume":"3","author":"Weber","year":"2010","journal-title":"Sci. Signal."},{"key":"B34","first-page":"424","article-title":"Preliminary criteria for classification of adult Still\u2019s disease.","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J. Rheumatol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00369\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T13:51:58Z","timestamp":1497361918000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00369\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,13]]},"references-count":34,"alternative-id":["10.3389\/fphar.2017.00369"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2017.00369","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,13]]},"article-number":"369"}}